Nektar Therapeutics
NKTR
#4504
Rank
โ‚ฌ2.05 B
Marketcap
60,72ย โ‚ฌ
Share price
-4.99%
Change (1 day)
556.33%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚ฌ0.14 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ55.23 Million. a decrease over its 2024 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚ฌ0.14 Billion30.44%
2024 -โ‚ฌ0.11 Billion-56.85%
2023 -โ‚ฌ0.24 Billion-24.31%
2022 -โ‚ฌ0.32 Billion-30.25%
2021 -โ‚ฌ0.45 Billion17.87%
2020 -โ‚ฌ0.39 Billion0.88%
2019 -โ‚ฌ0.38 Billion-164.46%
2018 โ‚ฌ0.58 B-810.61%
2017 -โ‚ฌ82.61 Million-37.06%
2016 -โ‚ฌ0.14 Billion89.22%
2015 -โ‚ฌ69.37 Million48.22%
2014 -โ‚ฌ46.8 Million-65.93%
2013 -โ‚ฌ0.14 Billion-6.81%
2012 -โ‚ฌ0.15 Billion28.95%
2011 -โ‚ฌ0.12 Billion258.8%
2010 -โ‚ฌ31.87 Million-63.94%
2009 -โ‚ฌ88.37 Million-392.45%
2008 โ‚ฌ30.21 M-211.74%
2007 -โ‚ฌ27.05 Million-79.57%
2006 -โ‚ฌ0.14 Billion-16.9%
2005 -โ‚ฌ0.16 Billion81.53%
2004 -โ‚ฌ87.75 Million54.19%
2003 -โ‚ฌ56.91 Million-33.87%
2002 -โ‚ฌ86.05 Million-9.6%
2001 -โ‚ฌ95.19 Million73.39%
2000 -โ‚ฌ54.9 Million108.9%
1999 -โ‚ฌ26.28 Million39.48%
1998 -โ‚ฌ18.85 Million60.02%
1997 -โ‚ฌ11.78 Million18.05%
1996 -โ‚ฌ9.98 Million31.82%
1995 -โ‚ฌ7.57 Million57.14%
1994 -โ‚ฌ4.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.33 B-16,808.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.10 B-6,911.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.81 B-5,944.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.44 Billion 226.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.30 B-8,558.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.60 B-9,531.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ0.86 M-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.20 B-252.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland